NESN.SW - Nestle S.A.

Swiss - Swiss Delayed price. Currency in CHF
101.08
+1.24 (+1.24%)
At close: 5:31PM CEST
Stock chart is not supported by your current browser
Previous close99.84
Open100.46
Bid0.00 x 0
Ask0.00 x 0
Day's range99.17 - 101.38
52-week range83.37 - 113.20
Volume6,693,526
Avg. volume9,377,856
Market cap291.115B
Beta (5Y monthly)0.37
PE ratio (TTM)23.51
EPS (TTM)4.30
Earnings date13 Feb 2020
Forward dividend & yield2.70 (2.70%)
Ex-dividend date27 Apr 2020
1y target est87.75
  • Nestle buys Lily's Kitchen pet food, sees some coronavirus stockpiling
    Reuters

    Nestle buys Lily's Kitchen pet food, sees some coronavirus stockpiling

    Nestle bought London-based Lily's Kitchen that makes food for dogs and cats in the higher-priced segment, the Swiss group said on Wednesday, as it bulks up in pet food, its fastest-growing product category. Purina PetCare had 7.0% organic growth and sales of 13.622 billion Swiss francs ($14.12 billion) in 2019, outpacing Nestle's other categories. Most of Lily's Kitchen's products are in the so-called premium segment that grew at a double-digit rate for Nestle last year.

  • Nestle staff to get full salary for three months where COVID-19 halts work
    Reuters

    Nestle staff to get full salary for three months where COVID-19 halts work

    The move will cover both part-time and salaried employees as well as those working in its retail operations - the Kit Kat Chocolatory and Nespresso boutiques - which have been temporarily closed in some places, the company said in a statement. It will also pay bonuses to salaried employees of its Canadian factories who cannot work from home. "The COVID-19 pandemic is a global problem and consequently we are offering help on the ground everywhere," Nestle Chief Executive Officer Mark Schneider said in a statement.

  • Nestle says cuts deforestation in its cocoa supply chain
    Reuters

    Nestle says cuts deforestation in its cocoa supply chain

    Nestle, the world's biggest food company, says it has made significant progress removing cocoa produced in protected forests in West Africa from its supply chain as pressure builds from consumers and governments for ethically sourced cocoa. The company said it had mapped, using GPS co-ordinates, 75% of the 120,000 cocoa farms it sources from directly in Ivory Coast and Ghana, which produce some two thirds of the world's cocoa. It found around 3,700 farms in protected forests in the process of mapping, and removed them from its supply chain.

  • Nestle CEO tells staff to get ready for coronavirus storm: memo
    Reuters

    Nestle CEO tells staff to get ready for coronavirus storm: memo

    Food giant Nestle told employees to prepare for difficult times ahead and make all the necessary efforts to supply customers with the food and beverages they need, Chief Executive Mark Schneider said in a memorandum seen by Reuters. "This is the moment for extra effort, for going the extra mile," Schneider said in a message to staff, distributed internally on Friday. "Please get ready for the storm to hit – because hit it will," Schneider added.

  • Nestle Picks JPMorgan to Handle China’s Yinlu Sale
    Bloomberg

    Nestle Picks JPMorgan to Handle China’s Yinlu Sale

    (Bloomberg) -- Nestle SA has chosen JPMorgan Chase & Co. to handle the sale of its Chinese unit Yinlu Foods Group, in a deal that could value the business at about $1 billion, people with knowledge of the matter said.The world’s largest food company is working with JPMorgan to prepare for the potential divestment, said the people, who asked not to be identified as the information is private. Nestle is reaching out to potential buyers including Chinese food and beverage companies like Dali Foods Group Co., Hangzhou Wahaha Group Co. and Uni-President China Holdings Ltd., the people said.Nestle plans to offload a majority stake in Yinlu and may retain a small holding to oversee the production of Nescafe ready-to-drink coffee, which Yinlu co-manufactures in China, one of the people said. The company currently plans to call for first-round bids as soon as late April or early May, yet the coronavirus outbreak could delay the process, according to the people.Yinlu is famous for its ready-made Chinese porridge, and was acquired by Nestle in 2011. The Swiss company sought to tap the burgeoning demand in China, only to find itself confronted with sluggish growth a few years later. Since becoming chief executive officer in 2017, Mark Schneider has been weeding out Nestle’s portfolio, divesting assets such as a dermatology business and its U.S. ice-cream business.Nestle’s restructuring costs and other expenses tripled to 2.6 billion francs ($2.8 billion) last year, largely led by a write-down of Yinlu’s value. Chief Financial Officer Francois-Xavier Roger said last month that not everything with Yinlu is negative as the Chinese company contributes to Nestle’s leading position in ready-to-drink coffee in China.Read: Nestle’s M&A Appetite Rises as Sales Growth Lags Behind GoalDeliberations are at an early stage and details of the sale may change, said the people. Representatives for Nestle and JPMorgan declined to comment, while representatives for Dali Foods, Wahaha and Uni-President China didn’t respond to requests for comment.Yinlu, which started its food business in 1985, specializes in the production and sale of canned foods and beverages. The company has five production facilities in Xiamen, Shandong, Hubei, Anhui and Sichuan with an annual capacity of up to 6 million tons, according to its website.Shares of Nestle fell as much as 6.4% in Zurich on Thursday as global stocks plunged into bear market on heightened concerns over the spread of the coronavirus.(Updates to add Nestle’s share price in last paragraph.)\--With assistance from Corinne Gretler and Daniela Wei.To contact the reporters on this story: Vinicy Chan in Hong Kong at vchan91@bloomberg.net;Dong Cao in Beijing at dcao59@bloomberg.netTo contact the editors responsible for this story: Fion Li at fli59@bloomberg.net, David Morris (News)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

  • Nestle bets on shark tank, startups and students to boost innovation
    Reuters

    Nestle bets on shark tank, startups and students to boost innovation

    Food giant Nestle has set up new structures to turn innovative ideas from outside and inside the company into new products, its technology head told journalists on Wednesday ahead of the publication of the group's full-year results. Employees, often from Nestle's research teams, can apply for funding to develop products via the company's internal ideas factory or "shark tank", while startups or students can work with Nestle scientists and resources, including lab space, at so-called "accelerators". Nestle and its packaged food peers have come under pressure to speed up innovation from a flurry of small local rivals that win over health and eco-conscious consumers with trendy foods and drinks, from cold-brew coffee to plant-based burgers.

  • Nestle invests $200 million more in Aimmune after peanut allergy drug approval
    Reuters

    Nestle invests $200 million more in Aimmune after peanut allergy drug approval

    The funding brings Nestle's total investment to $473 million, increasing the Swiss company's stake to 19.9% of Aimmune's outstanding stock and voting power. Nestle's investment is an incremental positive for Aimmune's shares, which have seen some weakness due to investor worries over financing, Piper Sandler analyst Christopher Raymond wrote in a note. "With this additional investment, we think the prospect of an outright take out by Nestle (or anyone else for that matter) has to be factored in more than before," Raymond said.

  • AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys
    Reuters

    AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys

    U.S. drugmaker AbbVie's $63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company is shedding to placate regulators. AbbVie is swallowing Allergan to give it control of the lucrative wrinkle treatment Botox and to diversify a portfolio heavily dependent on its $19-billion-per-year arthritis drug Humira, the world's best-selling medicine that is advancing toward U.S. patent expiration. Swiss food group Nestle bulked up its medical nutrition business with Allergan's Zenpep, a product with 2018 sales of $237 million which treats people whose pancreases do not provide enough enzymes to digest fats, proteins and sugars.

  • Nestle teams up with Canadian plant-based ingredient makers
    Reuters

    Nestle teams up with Canadian plant-based ingredient makers

    WINNIPEG, Manitoba/ZURICH (Reuters) - Food company Nestle SA said on Friday it has teamed up with small Canadian plant-based food ingredient makers Burcon and Merit Functional Foods, the second such supply agreement this month that targets Canadian crops. Canada is among the world's largest growers of peas and the biggest producer of canola, crops high in protein that technology companies like Burcon can separate and isolate for use in foods and beverages. The agreement with Nestle is long-term, with no expiry, Burcon Chief Executive Johann Tergesen said in an interview.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more